| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/24/2008 | WO2008111862A3 Methods and compositions for manipulating mammalian embryos |
| 12/24/2008 | WO2008101179A3 Use of sucrose to suppress mannitol-induced protein aggregation |
| 12/24/2008 | WO2008097503A3 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
| 12/24/2008 | WO2008085543A3 Multimeric elp fusion constructs |
| 12/24/2008 | WO2008079672A3 Flowable carrier compositions for orthopedic implants and methods of use |
| 12/24/2008 | WO2008073631A3 Composition for cartilage |
| 12/24/2008 | WO2008067279A3 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 12/24/2008 | WO2008055196A3 Genemap of the human genes associated with male pattern baldness |
| 12/24/2008 | WO2008052165A3 Method for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis |
| 12/24/2008 | WO2008051818A3 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 12/24/2008 | WO2008036350A3 Aldehyde tags, uses thereof in site-specific protein modification |
| 12/24/2008 | WO2008036157A3 Prophylactic and therapeutic treatment of avian influenza infections in animals |
| 12/24/2008 | WO2008033488A3 Polypeptides for bone mineralization |
| 12/24/2008 | WO2008033374A3 Ocl-2a3 compositions and uses thereof |
| 12/24/2008 | WO2008021088A3 Salicylanilides enhance oral delivery of therapeutic peptides |
| 12/24/2008 | WO2008019368A3 Albumin-insulin fusion proteins |
| 12/24/2008 | WO2008010991A3 Methods and compositions for the treatment of cancer |
| 12/24/2008 | WO2008008998A3 Reagents for the detection of protein phosphorylation in signaling pathways |
| 12/24/2008 | WO2008008358A3 Anti-cocaine compositions and treatment |
| 12/24/2008 | WO2007133580A3 Use of pth (1-31) and optionally g-csf for hematopoietic stimulation |
| 12/24/2008 | WO2007130726A3 Methods for the detection of cancer |
| 12/24/2008 | WO2007127327A3 Nanopore sensor system |
| 12/24/2008 | WO2007124414A3 Cxcl13 antagonists and their use for the treatment of inflammatory diseases |
| 12/24/2008 | WO2007121326A3 Compositions and methods for modulating gene expression |
| 12/24/2008 | WO2007120847A3 Identifying and modulating molecular pathways that mediate nervous system plasticity |
| 12/24/2008 | WO2007092453A3 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 12/24/2008 | WO2007075447A3 Compositions and methods for oxalate reduction |
| 12/24/2008 | WO2006088508A3 Cupredoxin derived transport agents and methods of use thereof |
| 12/24/2008 | EP2006384A1 Preprocalcitonin-derived antigen epitopes |
| 12/24/2008 | EP2006303A1 Recombinant antibodies specific for Beta-Amyloid ends, DNA encoding and methods of use thereof |
| 12/24/2008 | EP2006301A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2006294A1 Tumour-associated peptides that bind to MHC molecules |
| 12/24/2008 | EP2005996A2 Immunotherapeutic combination for the treatment of tumors |
| 12/24/2008 | EP2005967A1 Use of leptin in the treatment of alterations in food habits |
| 12/24/2008 | EP2005966A1 Survivin-derived peptides and use thereof |
| 12/24/2008 | EP2005944A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 12/24/2008 | EP2005171A2 Inflammation-inhibitory serum factors and uses thereof |
| 12/24/2008 | EP2004860A2 Methylation of estrogen receptor alpha and uses thereof |
| 12/24/2008 | EP2004844A2 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 12/24/2008 | EP2004837A2 Neutralizing agents for bacterial toxins |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004680A2 N-terminal vdac variants and uses thereof |
| 12/24/2008 | EP2004676A2 Peptide sequences and compositions |
| 12/24/2008 | EP2004675A1 Combination of cytokine and cytokine receptor for altering immune system functioning |
| 12/24/2008 | EP2004674A1 Antimicrobial protein |
| 12/24/2008 | EP2004673A1 Immunomodulating oligopeptides |
| 12/24/2008 | EP2004672A2 A process for concentration of a polypeptide |
| 12/24/2008 | EP2004633A2 Linear natriuretic peptide constructs |
| 12/24/2008 | EP2004352A2 Amino acid surrogates for peptidic constructs |
| 12/24/2008 | EP2004239A2 Novel integrin binding rgd-lipopeptides with gene transfer activities |
| 12/24/2008 | EP2004217A1 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 12/24/2008 | EP2004216A1 Agent for the treatment of hormone-dependent disorders and uses thereof |
| 12/24/2008 | EP2004215A1 Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase |
| 12/24/2008 | EP2004214A1 Methods for local treatment with factor vii |
| 12/24/2008 | EP2004213A1 Glp-1 peptide agonists |
| 12/24/2008 | EP2004212A1 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| 12/24/2008 | EP2004211A1 Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
| 12/24/2008 | EP2004210A2 Antiangiogenic peptide and therapeutic uses thereof |
| 12/24/2008 | EP2004209A2 Composition and method for stabilizing corneal tissue after refractive surgery |
| 12/24/2008 | EP2004202A1 Use of a growth-stimulating protein |
| 12/24/2008 | EP2003991A1 Novel nutraceutical compositions |
| 12/24/2008 | EP2003969A2 Mature dendritic cell compositions and methods for culturing same |
| 12/24/2008 | EP1871802A4 Recombinant e-selectin made in insect cells |
| 12/24/2008 | EP1519953B1 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s) |
| 12/24/2008 | EP1401418B1 Topical treatments using alkanolamines |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1181555B1 Cancer treatment with endothelin receptor antagonists |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | EP1012174B1 Nik proteins, nucleic acids and methods |
| 12/24/2008 | EP0909277B2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 12/24/2008 | EP0850047B1 Therapeutic lipidic vesicles: methods of use and compositions |
| 12/24/2008 | DE202007018629U1 Flüssigformulierung von G-CSF Liquid formulation of G-CSF |
| 12/24/2008 | CN101330922A Treatment of hypersensitivity |
| 12/24/2008 | CN101328483A Chrysalid pteromalid antibiotic protein Pp-Ap1 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328482A Chrysalid pteromalid antibiotic protein Pp-AP2 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328481A Chrysalid pteromalid antibiotic protein Pp-AP3 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328480A Chrysalid pteromalid antibiotic protein Pp-AP4 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328479A Chrysalid pteromalid antibiotic protein Pp-AP5 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328478A Protein having antiplatelet embolism activity, production method and use thereof |
| 12/24/2008 | CN101328472A Epidermal growth factor culture fluid, externally used drug for curing diabetes trauma using the culture fluid and preparation of the externally used drug |
| 12/24/2008 | CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 12/24/2008 | CN101328220A Preparation and use of galactosylated human serum albumin fused interferon |
| 12/24/2008 | CN101328213A G-CSF conjugates |
| 12/24/2008 | CN101328207A Citrus fruit fly antibacterial peptide, preparation and use thereof |
| 12/24/2008 | CN101327327A PEGylated recombined Aspergillus flavus uricoxidase coupling compound and preparation technique |
| 12/24/2008 | CN101327325A Ophthalmologic irrigation solutions and method |
| 12/24/2008 | CN101327322A Red eye virus eye-cleaning dew |
| 12/24/2008 | CN101327321A Soft capsules containing lactase |
| 12/24/2008 | CN101327320A Enzyme treatment for infection |
| 12/24/2008 | CN101327319A Use of DNA enzyme as medicament and preparation |
| 12/24/2008 | CN101327318A Mesenchyma stem cell suspension containing cell growth factor and uses thereof |
| 12/24/2008 | CN101327317A Use of human erythrocyte membrane protein of foreign body in preparing medicament for treating cancer |
| 12/24/2008 | CN101327316A Formulation for treating and preventing acalcerosis |
| 12/24/2008 | CN101327315A Use of maltose binding protein as immunopotentiator |
| 12/24/2008 | CN101327314A Nosiheptide-sulfuric acid colimycin premix and preparation and using method thereof |
| 12/24/2008 | CN101326953A Anti-hypertensive casein active peptide and method for producing the same as well as use thereof |
| 12/24/2008 | CN100445390C High activity, low antigen glucokinase derivant and preparation method |
| 12/24/2008 | CN100445389C Low antigen recombination glucokinase mutant and its preparation method |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |